Numeric Investors’s Travere Therapeutics TVTX Stock Holding History

Numeric Investors’s Portfolio TVTX Stock Details TVTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$801K	Buy	38,035 +35	+0.1%	+$800	0.01%	797
2017 Q3	$946K	Buy	38,000 +13,200	+53%	+$291K	0.01%	767
2017 Q2	$481K	Sell	24,800 -151,500	-86%	-$2.75M	﹤0.01%	835
2017 Q1	$3.25M	Sell	176,300 -62,500	-26%	-$1.22M	0.03%	397
2016 Q4	$4.52M	Sell	238,800 -7,000	-3%	-$143K	0.04%	348
2016 Q3	$5.5M	Buy	+245,800	New	+$4.68M	0.05%	300
2015 Q4	–	Sell	-48,000	Closed	-$972K	–	1132
2015 Q3	$972K	Sell	48,000 -93,043	-66%	-$2.76M	0.01%	546
2015 Q2	$4.68M	Buy	+141,043	New	+$3.86M	0.05%	262

Other funds holding TVTX

SCM

Scopia Capital Management New York $146M AUM 25.93% 1-Year Est. Return

CCM

Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Numeric Investors's TVTX Position: Q4 2017 in Review

Numeric Investors increased its Travere Therapeutics (TVTX) stake by 0.09% in Q4 2017, buying an estimated $800 and bringing the position to 38,035 shares worth $801K. The position accounts for 0.01% of the portfolio, ranked #797.

Numeric Investors first reported a position in TVTX in Q2 2015 and has held it in 8 quarters since. The position peaked at $5.5M in Q3 2016. 120 funds tracked by Wall St. Rank hold TVTX as of Q4 2017.

Numeric Investors held 38,035 shares of Travere Therapeutics worth $801K as of Q4 2017.
Numeric Investors bought 35 Travere Therapeutics shares in Q4 2017, an estimated $800.
Travere Therapeutics made up 0.01% of Numeric Investors's portfolio in Q4 2017, its #797 holding.
Numeric Investors first reported a position in Travere Therapeutics in Q2 2015 and has held it in 8 quarters since.
Numeric Investors's Travere Therapeutics position peaked at $5.5M in Q3 2016.
120 funds tracked by Wall St. Rank held Travere Therapeutics as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.